EUROPEAN NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY RELATED TO ADHERENCE TO THE RISK MINIMIZATION MEASURES FOR ROMOSOZUMAB BY THE EU-ADR ALLIANCEFirst published 24/09/2020 Last updated 17/06/2024 EU PAS number: EUPAS35956StudyOngoing